{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:06:29Z","timestamp":1792076789714,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["O514P51131"],"award-info":[{"award-number":["O514P51131"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["O812P1A131"],"award-info":[{"award-number":["O812P1A131"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese National Key Project","award":["2008ZX10002-014"],"award-info":[{"award-number":["2008ZX10002-014"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.bbagen.2012.08.017","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T03:03:15Z","timestamp":1346122995000},"page":"1886-1892","source":"Crossref","is-referenced-by-count":8,"title":["Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro"],"prefix":"10.1016","volume":"1820","author":[{"given":"Leiyun","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Watashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunitada","family":"Shimotohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaji","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2012.08.017_bb0005","series-title":"Fields Virology","first-page":"1253","article-title":"Hepatitis C virus","author":"Lemon","year":"2007"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0010","doi-asserted-by":"crossref","first-page":"10583","DOI":"10.1073\/pnas.90.22.10583","article-title":"A second hepatitis C virus-encoded proteinase","volume":"90","author":"Grakoui","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1369-5274(02)00341-7","article-title":"Interaction between hepatitis C virus proteins and host cell factors","volume":"5","author":"Tellinghuisen","year":"2002","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0020","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1006\/bbrc.2001.6333","article-title":"Kinetic analysis of C-terminally truncated RNA-dependent RNA polymerase of hepatitis C virus","volume":"290","author":"Kashiwagi","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/j.1460-2075.1996.tb00329.x","article-title":"Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"15","author":"Behrens","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0030","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1073\/pnas.87.17.6547","article-title":"Hepatitis C virus infection is associated with the development of hepatocellular carcinoma","volume":"87","author":"Saito","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0065-3527(04)63002-8","article-title":"Novel insights into hepatitis C virus replication and persistence","volume":"63","author":"Bartenschlager","year":"2004","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0040","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","article-title":"Viral hepatitis C","volume":"362","author":"Poynard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0045","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0050","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0055","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0060","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-0031-1297928","article-title":"The era of direct-acting antivirals has begun: the beginning of the end for HCV?","volume":"31","author":"Vachon","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.21102","article-title":"The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro","volume":"43","author":"Paeshuyse","year":"2006","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0075","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/AAC.00310-06","article-title":"NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon","volume":"50","author":"Ma","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/AAC.00660-09","article-title":"SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro","volume":"54","author":"Hopkins","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev-med-042010-085715","article-title":"Novel therapies for hepatitis C: insights from the structure of the virus","volume":"63","author":"Fusco","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0090","doi-asserted-by":"crossref","first-page":"e13687","DOI":"10.1371\/journal.pone.0013687","article-title":"DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A","volume":"5","author":"Coelmont","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0095","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.6238408","article-title":"Cyclophilin: a specific cytosolic binding protein for cyclosporin A","volume":"226","author":"Handschumacher","year":"1984","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(98)00242-7","article-title":"The mode of action of peptidyl prolyl cis\/trans isomerases in vivo: binding vs. catalysis","volume":"426","author":"Fischer","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0105","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nm910","article-title":"Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors","volume":"9","author":"Towers","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/372359a0","article-title":"Specific incorporation of cyclophilin A into HIV-1 virions","volume":"372","author":"Franke","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00535-002-1104-5","article-title":"Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial","volume":"38","author":"Inoue","year":"2003","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2003.11.080","article-title":"Specific inhibition of hepatitis C virus replication by cyclosporin A","volume":"313","author":"Nakagawa","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bmt.1700996","article-title":"Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplantation Team","volume":"20","author":"Akiyama","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0130","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/jhep.2003.50449","article-title":"Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes","volume":"38","author":"Watashi","year":"2003","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0135","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.21809","article-title":"Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B","volume":"46","author":"Fernandes","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0140","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1128\/JVI.02524-06","article-title":"Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro","volume":"81","author":"Robida","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0150","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/JVI.02614-07","article-title":"Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro","volume":"82","author":"Yang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0155","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1349-7006.2009.01263.x","article-title":"Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor","volume":"100","author":"Goto","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0160","doi-asserted-by":"crossref","first-page":"16998","DOI":"10.1074\/jbc.M109.007625","article-title":"The isomerase active site of cyclophilin a is critical for hepatitis C virus replication","volume":"284","author":"Chatterji","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0165","doi-asserted-by":"crossref","first-page":"e9815","DOI":"10.1371\/journal.pone.0009815","article-title":"cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A","volume":"5","author":"Fernandes","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0170","doi-asserted-by":"crossref","first-page":"e1000546","DOI":"10.1371\/journal.ppat.1000546","article-title":"Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics","volume":"5","author":"Kaul","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0175","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.1074\/jbc.M110.182436","article-title":"Domain 3 of NS5A protein from the hepatitis C virus has intrinsic {alpha}-helical propensity and is a substrate of cyclophilin A","volume":"286","author":"Verdegem","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001118","article-title":"A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach","volume":"6","author":"Yang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00705-009-0366-0","article-title":"Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain","volume":"154","author":"Weng","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0190","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1128\/JVI.00638-10","article-title":"Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner","volume":"84","author":"Weng","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0195","doi-asserted-by":"crossref","first-page":"e1000885","DOI":"10.1371\/journal.ppat.1000885","article-title":"RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells","volume":"6","author":"Murayama","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gene.2012.01.044","article-title":"Detergent-induced activation of the hepatitis C virus genotype 1b RNA polymerase","volume":"496","author":"Weng","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0205","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1128\/JVI.80.9.4510-4520.2006","article-title":"Diverse effects of cyclosporine on hepatitis C virus strain replication","volume":"80","author":"Ishii","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0210","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1128\/JVI.06641-11","article-title":"A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates alisporivir susceptibility","volume":"86","author":"Grise","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0215","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jhep.2010.01.041","article-title":"HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors","volume":"53","author":"Chatterji","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0220","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1128\/JVI.00393-11","article-title":"Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner","volume":"85","author":"Foster","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.22987","article-title":"Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A","volume":"50","author":"Liu","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0230","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.22131","article-title":"The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus","volume":"47","author":"Flisiak","year":"2008","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0235","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2005.06.031","article-title":"Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins","volume":"129","author":"Nakagawa","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0240","doi-asserted-by":"crossref","first-page":"13522","DOI":"10.1073\/pnas.212504399","article-title":"Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0245","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1006\/jmbi.1993.1664","article-title":"X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1 A resolution","volume":"234","author":"Mikol","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/361091a0","article-title":"X-ray structure of a decameric cyclophilin\u2013cyclosporin crystal complex","volume":"361","author":"Pflugl","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0255","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/AAC.01236-09","article-title":"Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors","volume":"54","author":"Puyang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0260","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1099\/vir.0.018531-0","article-title":"Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes","volume":"91","author":"Chatterji","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0265","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1128\/JVI.02550-08","article-title":"Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex","volume":"83","author":"Liu","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0270","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bcp.2008.12.019","article-title":"Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase","volume":"77","author":"Heck","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0275","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/13543780802651583","article-title":"An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C","volume":"18","author":"Crabbe","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.abb.2006.07.012","article-title":"Regulation of magnesium homeostasis and transport in mammalian cells","volume":"458","author":"Romani","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0285","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuro.2007.09.001","article-title":"Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats. An electron spectroscopy imaging and electron energy-loss spectroscopy study","volume":"29","author":"Morello","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0290","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.neuro.2008.02.012","article-title":"Manganese accumulates primarily in nuclei of cultured brain cells","volume":"29","author":"Kalia","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0295","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1074\/jbc.M505920200","article-title":"Altered HIV-1 Gag protein interactions with cyclophilin A (CypA) on the acquisition of H219Q and H219P substitutions in the CypA binding loop","volume":"281","author":"Gatanaga","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0300","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1073\/pnas.91.9.3931","article-title":"Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A","volume":"91","author":"Price","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0305","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1073\/pnas.88.5.1903","article-title":"Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence","volume":"88","author":"Price","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0310","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1021\/bi060511j","article-title":"Mechanistic study of HCV polymerase inhibitors at individual steps of the polymerization reaction","volume":"45","author":"Liu","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0315","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1021\/bi991992s","article-title":"Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays","volume":"39","author":"Carroll","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0320","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0325","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2012.08.017_bb0330","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2012.08.017_bb0335","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416512002371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416512002371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T04:55:54Z","timestamp":1562129754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416512002371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0304416512002371"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2012.08.017","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}